Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Wall Street
Price Targets
Price Targets Summary
Zhejiang Shouxiangu Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Zhejiang Shouxiangu Pharmaceutical Co Ltd is 64 CNY .
Price Targets
Revenue
Forecast
Revenue Estimate
Zhejiang Shouxiangu Pharmaceutical Co Ltd
For the last 7 years the compound annual growth rate for Zhejiang Shouxiangu Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 16%.
Operating Income
Forecast
Operating Income Estimate
Zhejiang Shouxiangu Pharmaceutical Co Ltd
For the last 7 years the compound annual growth rate for Zhejiang Shouxiangu Pharmaceutical Co Ltd's operating income is 23%. The projected CAGR for the next 1 year is -31%.
Net Income
Forecast
Net Income Estimate
Zhejiang Shouxiangu Pharmaceutical Co Ltd
For the last 7 years the compound annual growth rate for Zhejiang Shouxiangu Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 21%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's stock price target?
Price Target
64
CNY
According to Wall Street analysts, the average 1-year price target for Zhejiang Shouxiangu Pharmaceutical Co Ltd is 64 CNY .
What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
16%
For the last 7 years the compound annual growth rate for Zhejiang Shouxiangu Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 16%.
What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-31%
For the last 7 years the compound annual growth rate for Zhejiang Shouxiangu Pharmaceutical Co Ltd's operating income is 23%. The projected CAGR for the next 1 year is -31%.
What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
21%
For the last 7 years the compound annual growth rate for Zhejiang Shouxiangu Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 21%.